Coordinating new molecule chemistry through the DMTA cycle has never been more important or more challenging. We will demonstrate how pharmaceutical and biotechnology organizations can accelerate drug discovery programs through improved information dissemination, team work, and knowledge capture by implementing specialized interfaces for molecule design, synthesis management, biological test requests, and data analysis, that help take control of the small molecule life cycle.
Learn how to:
- Make better design decisions and track compound synthesis from start to finish
- Inspire your discovery chemistry teams to work together
- Design molecules faster, capture and share knowledge, and manage your resources with ease
Dr Tim Cheeseright
After a DPhil in Chemistry at the University of Oxford, Tim gained experience as a medicinal chemist and a molecular modeler at Peptide Therapeutics and Medivir. He joined Cresset immediately after its founding in 2002 and was appointed CEO of Torx Software in 2020.